Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Reports
Submitted on March 11, 2008 Regulation of CD45 Alternative Splicing by Heterogeneous Ribonucleoprotein, HnRNPLL , ,
1 Department of Pathology, Immune Disease Institute, Harvard Medical School, Boston, MA, 02115, USA. * To whom correspondence should be addressed.
The transition from naïve to activated T cells is marked by alternative splicing of pre–messenger RNA encoding the transmembrane phosphatase CD45. Using a short hairpin RNA screen, we identified heterogeneous ribonucleoprotein L-like (hnRNPLL) as a critical inducible regulator of CD45 alternative splicing. HnRNPLL was up-regulated in stimulated T cells, bound CD45 transcripts, and was both necessary and sufficient for CD45 alternative splicing. Depletion or overexpression of hnRNPLL in B and T cell lines and primary T cells resulted in reciprocal alteration of CD45RA and RO expression. Exon array analysis suggested that hnRNPLL acts as a global regulator of alternative splicing in activated T cells. Induction of hnRNPLL during haematopoietic cell activation and differentiation may allow cells to rapidly shift their transcriptomes to favor proliferation and inhibit cell death.
The editors suggest the following Related Resources on Science sites:In Science Magazine
In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)